Diligent Pharma

About

Diligent Pharma is a quality and compliance organization based in Princeton, New Jersey, founded in 2018. The company offers a secure, centralized SaaS platform designed to help pharmaceutical and biotech companies discover, qualify, and manage clinical trial service providers. Their mission is to enhance quality, compliance, and efficiency in sponsor-vendor partnerships, ultimately accelerating the delivery of life-saving treatments to patients. The platform features tools for vendor discovery, streamlined qualification, risk management, and centralized oversight of vendor data. These functionalities enable faster trial execution and ensure adherence to regulatory standards. Diligent Pharma positions itself as a challenger in the clinical trial regulatory solutions market, competing with established companies like Veeva Systems and Medidata. The company raised $8.27 million in a Series A funding round in 2023, led by FCA Venture Partners, and is supported by a team of experts in clinical trial quality and technology.